The University of Texas MD Anderson Cancer Center and the MD Anderson Cancer Network Symposium - Clinical Program: A Multidisciplinary Approach to Individualized Patient Care and Nursing Excellence: Navigating the Changing Landscape of Oncology Nursing

The University of Texas MD Anderson Cancer Center and the MD Anderson Cancer Network Symposium - Clinical Program: A Multidisciplinary Approach to Individualized Patient Care and Nursing Excellence: Navigating the Changing Landscape of Oncology Nursing is organized by The University of Texas MD Anderson Cancer Center and will be held from Oct 12 - 13, 2019 at Marriott Marquis Houston, Houston, Texas, United States of America.

Target Audience:
This symposium will be beneficial to Medical Oncologists, Surgical Oncologists, Radiation Oncologists, General Surgeons, Internists, Researchers, Physician Assistants, Oncology Nurses and Advanced Practice Nurses.

Accreditation/Credit Designation:
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 17.00 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Ethics Credits:
The presentation, Increasing HPV Vaccine Confidence and Understanding HPV Vaccine Efficacy and Indications, has been designated by The University of Texas MD Anderson Cancer Center for a total of .25 AMA PRA Category CreditsTM in medical ethics and/or professional responsibility.

ABIM Maintenance of Certification:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Clinical Program: A Multidisciplinary Approach to Individualized Patient Care
Goal:
A multidisciplinary approach in the treatment of patients diagnosed with cancer has been the key for delivering high quality of care. A tsunami created by rapidly expanding knowledge in tumor molecular biology and immunology, moreover, new molecular approaches have enabled the development of therapeutics that target specific oncogenic mutations and immune checkpoints. This constant evolution has maintained a dynamic relationship with the disciplines - surgical, radiation therapy and medical oncology- modulating the approach in an individualized patient care. The advances and emerging data is much needed in community settings in order to deliver quality care and to improve patient outcomes.

Educational Objectives:
After attending the symposium, participants should be able to:
• Provide a multidisciplinary approach in the management of melanoma patients (Knowledge, Competence);
• Implement new practice changes in breast cancer treatment involving fields that will influence positively patient outcomes in terms of quality of life and survival (Knowledge, Competence, Performance, Patient Outcomes);
• Select the best strategies in surgery of gynecology malignancies to enhance post-op recovery, reduce morbidity and lead to better quality of life and outcomes (Knowledge, Competence, Performance, Patient Outcomes);
• Select the most appropriate gastrointestinal treatment option/modality (Knowledge, Competence);
• Utilize new management methods for genitourinary cancers (Knowledge, Competence, Performance);
• Utilize a multidisciplinary approach and targeted treatment strategies in the management of thyroid cancer (Knowledge, Competence, Performance);
• Understand molecular biology and immunology of brain metastases to utilize the most effective systemic treatments, targeted therapies, checkpoint inhibitors, neurosurgical procedures and radiation (Knowledge);
• Assess treatment guidelines, goals, monitoring tools and treatment approaches in care of hematologic malignancies (Knowledge, Competence);
• Select patients and identify the appropriate class of agents in the treatment of metastatic NSCLC and select local modalities of treatment for oligometastatic disease (Knowledge, Competence);
• Appreciate the role of salvage surgery in esophageal cancer (Knowledge);
• Appreciate the future status of CAR NK Cells, liquid biopsies, microbiome and of the emerging actionable mutations (Knowledge).

Nursing Excellence: Navigating the Changing Landscape of Oncology Nursing"
Goal:
The Nursing Excellence program focuses on current clinical topics across the continuum of oncology care. After attending this educational activity, the registered nurse will self-report an understanding of patient navigation practices in oncology, principles of cancer genetics and appropriate risk assessment, administration and management of immunotherapy and biosimilars, best practices in cancer care, ethical considerations in oncology, oncologic emergencies management, updates in head and neck cancer treatment, and the use of integrative medicine in oncology. The program will provide an opportunity to collaborate with MD Anderson Cancer Network and national colleagues and the potential to earn up to 13.75 nursing contact hours.

The University of Texas MD Anderson Cancer Center is an approved provider with commendation of continuing nursing education by the Texas Nurses Association – Approver, an accredited approver with distinction, by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses may earn upto 13.75 contact hours for both days.